This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Sonendo (SONX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sonendo (SONX) delivered earnings and revenue surprises of 33.33% and 9.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Inspire Medical Systems (INSP) Tops Q2 Earnings Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 328.57% and 0.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well (AMWL) delivered earnings and revenue surprises of 14.72% and 3.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Hims & Hers (HIMS) Stock Ahead of Q2 Earnings?
by Debanjana Dey
Continued solid uptake of Hims & Hers (HIMS) offerings and expanding subscriber base are likely to have driven its performance in the second quarter.
Sonendo, Inc. (SONX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sonendo (SONX) delivered earnings and revenue surprises of -244.44% and 11.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health, Inc. (HIMS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 150% and 2.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of -75% and 3.35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Sonendo, Inc. (SONX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sonendo, Inc. (SONX) delivered earnings and revenue surprises of -26.67% and 0.60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Nyxoah SA (NYXH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Nyxoah SA (NYXH) delivered earnings and revenue surprises of -8.89% and 15.64%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Sonendo, Inc. (SONX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sonendo, Inc. (SONX) delivered earnings and revenue surprises of -6.67% and 0.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Sonendo, Inc. (SONX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sonendo, Inc. (SONX) delivered earnings and revenue surprises of 45.45% and 5.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
After Plunging -15.02% in 4 Weeks, Here's Why the Trend Might Reverse for Sonendo, Inc. (SONX)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Sonendo, Inc. (SONX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CareCloud, Inc. (CCLD) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
CareCloud, Inc. (CCLD) delivered earnings and revenue surprises of -10% and 3.92%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of 19.05% and 5.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sonendo, Inc. (SONX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sonendo, Inc. (SONX) delivered earnings and revenue surprises of -20.51% and 7.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of -5.88% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sonendo, Inc. (SONX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Sonendo, Inc. (SONX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.